Tag : glaucoma

Latest News

Aerpio Pharmaceuticals Presents Data from Fifth Patient Cohort Showing Potential of Topical Ocular Formulation of AKB-9778 Product Candidate When Combined with Prostaglandin in Subjects with Primary Open Angle Glaucoma or Ocular Hypertension

Newsemia
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, announced that...
Latest News

New Technologies for Outcome Measures in Glaucoma: Review by the European Vision Institute Special Interest Focus Group.

Newsemia
Traber, GL; Della Volpe-Waizel, M; Maloca, P; Schmidt-Erfurth, U; Rubin, G; Roska, B; Cordeiro, MF; … Scholl, HPN; + view all Traber, GL; Della Volpe-Waizel,...
Latest News

Enhancing OCT signal by fusion of GANs: Improving statistical power of glaucoma clinical trials

Newsemia
Lazaridis, G; Lorenzi, M; Ourselin, S; Garway-Heath, D; (2019) Enhancing OCT signal by fusion of GANs: Improving statistical power of glaucoma clinical trials. In: Medical...
Latest News

'Eye-in-a-dish' model helps scientists to uncover 'surprising' AMD gene variant

Newsemia
Researchers have discovered a new genetic variant responsible for blood vessel dysregulation in the development of age-related macular degeneration (AMD). Source link...
Pharma / Biotech

A Highly Selective Rho-Kinase Inhibitor (ITRI-E-212) Potentially Treats Glaucoma Upon Topical Administration With Low Incidence of Ocular Hyperemia.

Newsemia
Related Articles A Highly Selective Rho-Kinase Inhibitor (ITRI-E-212) Potentially Treats Glaucoma Upon Topical Administration With Low Incidence of Ocular Hyperemia. Invest Ophthalmol Vis Sci. 2019...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy